Most cited papers from Milagen (United States)
What are the most cited papers from Milagen (United States)?
The most cited paper from Milagen (United States) is "Serum Protein Expression Profiling for Cancer Detection: Validation of a SELDI‐Based Approach for Prostate Cancer" (William E. Grizzle, Bao-Ling Adam, William L. Bigbee et al., 2004), with 67 citations. Next come "Compact Cas9d and HEARO enzymes for genome editing discovered from uncultivated microbes" (36) and "Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosis" (33).
Showing 17 of 17 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Serum Protein Expression Profiling for Cancer Detection: Validation of a SELDI‐Based Approach for Prostate Cancer William E. Grizzle, Bao-Ling Adam, William L. Bigbee et al. · Disease Markers | 2004 | 67 |
| 2 | Compact Cas9d and HEARO enzymes for genome editing discovered from uncultivated microbes Daniela S. Aliaga Goltsman, Lisa Mustone Alexander, Jyun‐Liang Lin et al. · Nature Communications | 15 Dec 2022 | 36 |
| 3 | Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosis Ujjini H. Manjunatha et al. · Nature Microbiology | 8 Oct 2024 | 33 |
| 4 | New approaches for biomarker discovery in lung cancer Rosaura P.C. Valle, Christine Chavany, Tatyana A Zhukov and Moncef Jendoubi · Expert Review of Molecular Diagnostics | 2003 | 27 |
| 5 | Antibody-based technologies for target discovery. Rosaura P.C. Valle, Moncef Jendoubi · PubMed | Mar 2003 | 17 |
| 6 | Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome Engineering Rebecca C. Lamothe, Meghan D. Storlie, Diego A. Espinosa et al. · The CRISPR Journal | 23 May 2023 | 13 |
| 7 | Novel Type V-A CRISPR Effectors Are Active Nucleases with Expanded Targeting Capabilities Daniela S. Aliaga Goltsman, Lisa Mustone Alexander, Audra E. Devoto et al. · The CRISPR Journal | 4 Nov 2020 | 12 |
| 8 | Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability Lisa Mustone Alexander et al. · The CRISPR Journal | Jun 2023 | 9 |
| 9 | Meiotic DNA break resection and recombination rely on chromatin remodeler Fun30 Pei-Ching Huang, Soogil Hong, Hasan F Alnaser et al. · The EMBO Journal | 29 Nov 2024 | 6 |
| 10 | CRISPR-AuNP: physicochemical optimization of a gold nanoparticle platform for cost-effective and modular non-viral gene editing in HSPCs Karthikeya S. V. Gottimukkala, Daniel D. Lane, Rachel Cunningham et al. · Gene Therapy | 14 Jan 2026 | 4 |
| 11 | 507 Phase 1/2a randomized, double-blind, placebo-controlled study: Safety, pharmacokinetics, and efficacy outcome measures of inhaled gallium citrate (AR-501) in people with cystic fibrosis A. Cohen, N. Lechtzin, K. McBennett et al. · Journal of Cystic Fibrosis | Oct 2022 | 3 |
| 12 | DNA targeting by compact Cas9d and its resurrected ancestor Rodrigo Fregoso Ocampo, Jack P. K. Bravo, Tyler L. Dangerfield et al. · bioRxiv (Cold Spring Harbor Laboratory) | 8 Apr 2024 | 1 |
| 13 | A Novel Protein Serum Biomarker Assay for Tracking (Neo)adjuvant and Metastatic Therapy Efficacy and Enabling the Timely Detection of Relapse in Breast Cancer Jeffrey Dea, Christine Chavany, Rosaura P.C. Valle et al. · Cancers | 16 Dec 2025 | 0 |
| 14 | Comparative characterization of Cas12f orthologs reveals mechanistic features underlying enhanced genome editing efficiency Kaoling Guan, Rodrigo Fregoso Ocampo, Paula B. Matheus Carnevali et al. · Nature Structural & Molecular Biology | 13 Apr 2026 | 0 |
| 15 | New breast cancer marker BF-09 is overexpressed in tumor extracts and secreted in serum Christine Chavany, Jeffrey Dea, Rafael Hernández González et al. · Biochemistry and Biophysics Reports | 20 Jun 2025 | 0 |
| 16 | Development of a serum-based immunoassay for prostate cancer detection. Christine Chavany, Steven S. Chen, Stephen R. Schramm et al. · Cancer Research | 15 Apr 2006 | 0 |
| 17 | Candidate serum biomarkers for predictive medicine and disease management of asthma J. Just, Christine Chavany, K Yamaguchi et al. · Journal of Allergy and Clinical Immunology | Feb 2004 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.